Albert D. Dyrness's Insider Trades & SAST Disclosures

Albert D. Dyrness's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 373 Common Stock done . Disclosure was reported to the exchange on Dec. 11, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Sonnet BioTherapeutics Hol...
D. Albert Dyrness Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2023 373 537 - - Common Stock
Sonnet BioTherapeutics Hol...
Albert D. Dyrness Director Purchase of securities on an exchange or from another person at price $ 0.47 per share. 30 May 2023 23,255 28,962 - 0.5 10,883 Common Stock
Sonnet BioTherapeutics Hol...
Albert D. Dyrness Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2022 3,770 30,893 - - Common Stock
Sonnet BioTherapeutics Hol...
Albert D. Dyrness None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jul 2020 8,005 12,971 - 0 Common Stock
Sonnet BioTherapeutics Hol...
Albert D. Dyrness None Purchase of securities on an exchange or from another person at price $ 4.01 per share. 11 Jun 2020 2,409 4,966 - 4.0 9,660 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades